Home » Topics » BioWorld Science

BioWorld Science
RSS

FemPatch approved for marketing in U.S.

Dec. 10, 1996

P&U anticipates filing for urinary incontinence treatment soon

Dec. 10, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

HemispheRx CFS diagnostic receives European patent approval

Dec. 10, 1996

Avitar's collection system marketed for DNA testing

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...